Annual EBITDA
-$124.69 M
-$9.65 M-8.39%
31 December 2022
Summary:
Provention Bio annual earnings before interest, taxes, depreciation & amortization is currently -$124.69 million, with the most recent change of -$9.65 million (-8.39%) on 31 December 2022. During the last 3 years, it has fallen by -$25.62 million (-25.86%).PRVB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$38.02 M
-$9.79 M-34.66%
31 December 2022
Summary:
Provention Bio quarterly earnings before interest, taxes, depreciation & amortization is currently -$38.02 million, with the most recent change of -$9.79 million (-34.66%) on 31 December 2022.PRVB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$124.89 M
-$12.33 M-10.95%
31 December 2022
Summary:
Provention Bio TTM earnings before interest, taxes, depreciation & amortization is currently -$124.89 million, with the most recent change of -$12.33 million (-10.95%) on 31 December 2022.PRVB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRVB EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -25.9% | -41.2% | -2.9% |
| 5 y5 years | -365.0% | -281.2% | -214.7% |
PRVB EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +1264.2% | >+9999.0% | >+9999.0% |
Provention Bio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$124.69 M(+8.4%) | -$38.02 M(+34.7%) | -$124.89 M(+11.0%) |
| Sept 2022 | - | -$28.23 M(-4.9%) | -$112.57 M(+1.2%) |
| June 2022 | - | -$29.70 M(+2.6%) | -$111.26 M(-0.4%) |
| Mar 2022 | - | -$28.94 M(+12.7%) | -$111.65 M(-3.0%) |
| Dec 2021 | -$115.05 M(+16.1%) | -$25.69 M(-4.6%) | -$115.10 M(-5.2%) |
| Sept 2021 | - | -$26.93 M(-10.5%) | -$121.42 M(-3.6%) |
| June 2021 | - | -$30.09 M(-7.1%) | -$125.90 M(+6.2%) |
| Mar 2021 | - | -$32.40 M(+1.2%) | -$118.60 M(+19.7%) |
| Dec 2020 | -$99.07 M(+123.3%) | -$32.00 M(+1.9%) | -$99.07 M(+27.1%) |
| Sept 2020 | - | -$31.41 M(+37.8%) | -$77.95 M(+37.9%) |
| June 2020 | - | -$22.80 M(+77.2%) | -$56.52 M(+22.9%) |
| Mar 2020 | - | -$12.87 M(+18.2%) | -$45.98 M(+3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$44.37 M(+65.5%) | -$10.88 M(+9.1%) | -$44.37 M(+11.8%) |
| Sept 2019 | - | -$9.97 M(-18.6%) | -$39.69 M(+13.0%) |
| June 2019 | - | -$12.26 M(+8.9%) | -$35.13 M(+6.3%) |
| Mar 2019 | - | -$11.26 M(+81.6%) | -$33.04 M(+23.2%) |
| Dec 2018 | -$26.81 M(+193.4%) | -$6.20 M(+14.6%) | -$26.81 M(+10.1%) |
| Sept 2018 | - | -$5.41 M(-46.8%) | -$24.35 M(+19.9%) |
| June 2018 | - | -$10.16 M(+101.8%) | -$20.31 M(+43.7%) |
| Mar 2018 | - | -$5.04 M(+34.9%) | -$14.13 M(+54.6%) |
| Dec 2017 | -$9.14 M | -$3.73 M(+171.6%) | -$9.14 M(+64.1%) |
| Sept 2017 | - | -$1.38 M(-65.5%) | -$5.57 M(+32.8%) |
| June 2017 | - | -$3.99 M(+9172.1%) | -$4.20 M(+1916.8%) |
| Mar 2017 | - | -$43.00 K(-73.9%) | -$208.00 K(+26.1%) |
| Dec 2016 | - | -$165.00 K | -$165.00 K |
FAQ
- What is Provention Bio annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Provention Bio?
- What is Provention Bio quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Provention Bio?
- What is Provention Bio TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Provention Bio?
What is Provention Bio annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of PRVB is -$124.69 M
What is the all time high annual EBITDA for Provention Bio?
Provention Bio all-time high annual earnings before interest, taxes, depreciation & amortization is -$9.14 M
What is Provention Bio quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of PRVB is -$38.02 M
What is the all time high quarterly EBITDA for Provention Bio?
Provention Bio all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$43.00 K
What is Provention Bio TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of PRVB is -$124.89 M
What is the all time high TTM EBITDA for Provention Bio?
Provention Bio all-time high TTM earnings before interest, taxes, depreciation & amortization is -$165.00 K